These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9718275)

  • 1. Chemotherapy primes malignant glioma cells for CD95 ligand-induced apoptosis up-stream of caspase 3 activation.
    Hueber A; Winter S; Weller M
    Eur J Pharmacol; 1998 Jul; 352(1):111-5. PubMed ID: 9718275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Death ligand/receptor-independent caspase activation mediates drug-induced cytotoxic cell death in human malignant glioma cells.
    Glaser T; Wagenknecht B; Groscurth P; Krammer PH; Weller M
    Oncogene; 1999 Sep; 18(36):5044-53. PubMed ID: 10490841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-alpha enhances CD95L-induced apoptosis of human malignant glioma cells.
    Roth W; Wagenknecht B; Dichgans J; Weller M
    J Neuroimmunol; 1998 Jul; 87(1-2):121-9. PubMed ID: 9670853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 enhances BAK and CD95 expression in human malignant glioma cells but does not enhance CD95L-induced apoptosis.
    Pohl U; Wagenknecht B; Naumann U; Weller M
    Cell Physiol Biochem; 1999; 9(1):29-37. PubMed ID: 10352342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergy of CD95 ligand and teniposide: no role of cleavable complex formation and enhanced CD95 expression.
    Winter S; Roth W; Dichgans J; Weller M
    Eur J Pharmacol; 1998 Jan; 341(2-3):323-8. PubMed ID: 9543255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crm-A, bcl-2 and NDGA inhibit CD95L-induced apoptosis of malignant glioma cells at the level of caspase 8 processing.
    Wagenknecht B; Schulz JB; Gulbins E; Weller M
    Cell Death Differ; 1998 Oct; 5(10):894-900. PubMed ID: 10203695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy-induced apoptosis of S-type neuroblastoma cells requires caspase-9 and is augmented by CD95/Fas stimulation.
    Bian X; Giordano TD; Lin HJ; Solomon G; Castle VP; Opipari AW
    J Biol Chem; 2004 Feb; 279(6):4663-9. PubMed ID: 14617634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic drugs and the CD95 pathway.
    Friesen C; Fulda S; Debatin KM
    Leukemia; 1999 Nov; 13(11):1854-8. PubMed ID: 10557062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitization to CD95 ligand-induced apoptosis in human glioma cells by hyperthermia involves enhanced cytochrome c release.
    Hermisson M; Wagenknecht B; Wolburg H; Glaser T; Dichgans J; Weller M
    Oncogene; 2000 May; 19(19):2338-45. PubMed ID: 10822385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloma cells selected for resistance to CD95-mediated apoptosis are not cross-resistant to cytotoxic drugs: evidence for independent mechanisms of caspase activation.
    Landowski TH; Shain KH; Oshiro MM; Buyuksal I; Painter JS; Dalton WS
    Blood; 1999 Jul; 94(1):265-74. PubMed ID: 10381522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C2-ceramide signaling in glioma cells: synergistic enhancement of CD95-mediated, caspase-dependent apoptosis.
    Wagenknecht B; Roth W; Gulbins E; Wolburg H; Weller M
    Cell Death Differ; 2001 Jun; 8(6):595-602. PubMed ID: 11536010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunochemotherapy of malignant glioma: synergistic activity of CD95 ligand and chemotherapeutics.
    Roth W; Fontana A; Trepel M; Reed JC; Dichgans J; Weller M
    Cancer Immunol Immunother; 1997 Mar; 44(1):55-63. PubMed ID: 9111585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APO010, a synthetic hexameric CD95 ligand, induces human glioma cell death in vitro and in vivo.
    Eisele G; Roth P; Hasenbach K; Aulwurm S; Wolpert F; Tabatabai G; Wick W; Weller M
    Neuro Oncol; 2011 Feb; 13(2):155-64. PubMed ID: 21183510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release.
    Röhn TA; Wagenknecht B; Roth W; Naumann U; Gulbins E; Krammer PH; Walczak H; Weller M
    Oncogene; 2001 Jul; 20(31):4128-37. PubMed ID: 11464279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taxol-mediated augmentation of CD95 ligand-induced apoptosis of human malignant glioma cells: association with bcl-2 phosphorylation but neither activation of p53 nor G2/M cell cycle arrest.
    Roth W; Wagenknecht B; Grimmel C; Dichgans J; Weller M
    Br J Cancer; 1998; 77(3):404-11. PubMed ID: 9472635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced apoptosis in osteosarcoma cell lines is mediated by caspase activation independent of CD95-receptor/ligand interaction.
    Fellenberg J; Mau H; Nedel S; Ewerbeck V; Debatin KM
    J Orthop Res; 2000 Jan; 18(1):10-7. PubMed ID: 10716273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribavirin and alpha interferon enhance death receptor-mediated apoptosis and caspase activation in human hepatoma cells.
    Schlosser SF; Schuler M; Berg CP; Lauber K; Schulze-Osthoff K; Schmahl FW; Wesselborg S
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1912-21. PubMed ID: 12760867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of caspases in CD95-induced biphasic activation of acid sphingomyelinase.
    Stephan M; Edelmann B; Winoto-Morbach S; Janssen O; Bertsch U; Perrotta C; Schütze S; Fritsch J
    Oncotarget; 2017 Mar; 8(12):20067-20085. PubMed ID: 28223543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the CD95/CD95 ligand system in glucocorticoid-induced monocyte apoptosis.
    Schmidt M; Lügering N; Lügering A; Pauels HG; Schulze-Osthoff K; Domschke W; Kucharzik T
    J Immunol; 2001 Jan; 166(2):1344-51. PubMed ID: 11145719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel bis-benzylidenecyclopentanone derivative, BPR0Y007, inducing a rapid caspase activation involving upregulation of Fas (CD95/APO-1) and wild-type p53 in human oral epidermoid carcinoma cells.
    Juang SH; Pan WY; Kuo CC; Liou JP; Hung YM; Chen LT; Hsieh HP; Chang JY
    Biochem Pharmacol; 2004 Jul; 68(2):293-303. PubMed ID: 15194001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.